• Bio-Gate completed a private placement of 171,429 new shares from authorized capital at EUR 2.8 each.
• Subscription rights were excluded; gross proceeds totaled EUR 480,001.2.
• Proceeds are earmarked for short-term investments.
• The private placement formed part of a broader 415,000-share issuance at EUR 2.8, raising EUR 1.16 million gross.
• Share capital will rise to EUR 2,453,738 from EUR 2,038,738 following the capital measures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Gate AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2385032_en) on August 18, 2026, and is solely responsible for the information contained therein.